Insider Trading activities of Immune Response Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Immune Response Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Immune Response Corp since year 2005. Table 2 shows the detailed insider transactions of Immune Response Corp since 2005. The reporting company's ticker symbol is IMNR. The reporting company's CIK number is 817785.
The total value of stock buying since 2005 is $98,880.
The total value of stock sales since 2005 is $21,936,244.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Immune Response Corp (IMNR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2006-11 0 $0 7,145,000 $13,729,794 0 $0
2006-10 0 $0 1,075,000 $2,146,450 0 $0
2006-09 0 $0 2,330,000 $4,660,000 0 $0
2006-08 500,000 $9,000 700,000 $1,400,000 0 $0
2006-07 2,900,000 $66,400 0 $0 0 $0
2006-06 200,000 $4,000 0 $0 0 $0
2005-09 9,683,060 $19,480 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Immune Response Corp insiders (IMNR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2006-11-09 Green Michael K (COO and CFO) Sale 2,474,900 1.92 4,751,808
2006-11-08 Green Michael K (COO and CFO) Sale 1,770,000 1.90 3,363,000
2006-11-07 Green Michael K (COO and CFO) Sale 325,600 1.91 621,896
2006-11-06 Green Michael K (COO and CFO) Sale 158,000 1.91 301,780
2006-11-03 Green Michael K (COO and CFO) Sale 1,042,500 1.92 2,001,600
2006-11-02 Green Michael K (COO and CFO) Sale 1,041,000 1.96 2,040,360
2006-11-01 Green Michael K (COO and CFO) Sale 333,000 1.95 649,350
2006-10-31 Green Michael K (COO and CFO) Sale 355,000 1.99 706,450
2006-10-19 Theofan Georgia (VP, Clinical Development) Sale 720,000 2.00 1,440,000
2006-09-15 Theofan Georgia (VP, Clinical Development) Sale 150,000 2.00 300,000
2006-09-08 Theofan Georgia (VP, Clinical Development) Sale 2,180,000 2.00 4,360,000
2006-08-31 Theofan Georgia (VP, Clinical Development) Sale 200,000 2.00 400,000
2006-08-29 Theofan Georgia (VP, Clinical Development) Sale 250,000 2.00 500,000
2006-08-25 Theofan Georgia (VP, Clinical Development) Sale 250,000 2.00 500,000
2006-08-21 Hochman David P (Director) Buy 500,000 .02 9,000
2006-07-28 Hochman David P (Director) Buy 2,600,000 .02 59,800
2006-07-27 Hochman David P (Director) Buy 300,000 .02 6,600
2006-06-19 Hochman David P (Director) Buy 200,000 .02 4,000
2005-09-22 Kimberlin Kevin (10% Owner) Buy 9,643,060 .00 0
2005-09-06 Green Michael K (VP, Finance and CFO) Buy 30,000 .50 14,880
2005-09-02 Bonfiglio John N (CEO) Buy 10,000 .46 4,600

Insider trading activities including stock purchases, stock sales, and option exercises of IMNR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Immune Response Corp (symbol IMNR, CIK number 817785) see the Securities and Exchange Commission (SEC) website.